Treanda and Pepcid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Treanda (bendamustine hydrochloride) and Pepcid (famotidine). Common drug interactions include pyrexia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Treanda and Pepcid. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Treanda?

Treanda has active ingredients of bendamustine hydrochloride. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 4,411 Treanda users. Check the latest studies of Treanda.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

On Aug, 09, 2026

25 people who take Treanda and Pepcid together, and have interactions are studied.

What are the common drug interactions of Treanda and Pepcid, by gender? *:

female:

Pyrexia (fever)
Abdominal pain
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Atelectasis (partial or complete collapse of the lung)
Cardiac failure congestive
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Headache (pain in head)
Hypokalaemia (low potassium)

male:

Febrile neutropenia (fever with reduced white blood cells)
Dizziness
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site reaction
Mucosal inflammation (infection of mucous membrane)
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)
Oesophagitis (inflammation of oesophagus)
Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)

What are the common drug interactions of Treanda and Pepcid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Palpitations (feelings or sensations that your heart is pounding or racing)
Blood pressure increased
Chest discomfort
Chest pain
Febrile neutropenia (fever with reduced white blood cells)
Head discomfort
Headache (pain in head)
Heart rate increased

50-59:

Nausea (feeling of having an urge to vomit)
Vomiting
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Atelectasis (partial or complete collapse of the lung)
Cardiac failure congestive
Dehydration (dryness resulting from the removal of water)
Hypokalaemia (low potassium)
Leukocytosis (increased white blood cells)
Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
Pleural effusion (water on the lungs)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Diarrhoea
Demyelinating polyneuropathy (disorder that affects the nerves outside of the brain and spinal cord (peripheral nerves))
Dizziness
Gait disturbance
Headache (pain in head)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site reaction

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 14 people, 56.00%
Nausea (feeling of having an urge to vomit): 6 people, 24.00%
Pain: 5 people, 20.00%
Neuropathy Peripheral (surface nerve damage): 2 people, 8.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Treanda and Pepcid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously